N
PFE icon

Numerai’s Pfizer PFE Stock Holding History

Numerai’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,102
Closed -$202K – 857
2025
Q4 		$202K Buy
+8,102
New +$204K 0.02% 581
2025
Q1 		– Sell
-10,170
Closed -$270K – 569
2024
Q4 		$270K Hold
10,170
– – 0.07% 311
2024
Q3 		$294K Sell
10,170
-2,582
-20% -$75.3K 0.08% 278
2024
Q2 		$357K Sell
12,752
-35,702
-74% -$983K 0.13% 223
2024
Q1 		$1.34M Sell
48,454
-51,446
-51% -$1.43M 0.58% 51
2023
Q4 		$2.88M Buy
99,900
+77,427
+345% +$2.34M 1.02% 24
2023
Q3 		$745K Hold
22,473
– – 0.25% 117
2023
Q2 		$824K Buy
+22,473
New +$875K 0.17% 117

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Numerai's PFE Position: Q1 2026 in Review

Numerai sold out of Pfizer (PFE) in Q1 2026, closing a stake of 8,102 shares — an estimated $202K sold.

Numerai first reported a position in PFE in Q2 2023 and held it in 8 quarters. The position peaked at $2.88M in Q4 2023. 2,952 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Numerai reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Numerai sold 8,102 Pfizer shares in Q1 2026, an estimated $202K.
  • Numerai first reported a position in Pfizer in Q2 2023 and held it in 8 quarters.
  • Numerai's Pfizer position peaked at $2.88M in Q4 2023.
  • 2,952 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Numerai's 13F filing for Q1 2026, filed 15 May 2026.